A "class action" against the microenvironment: Do cancer cells cooperate in metastasis?

Cancer and Metastasis Reviews

Volumn 27, Issue 1, 2008, Pages 5-10

  Bidard, François Clément ^a   Pierga, Jean Yves ^a   Vincent Salomon, Anne ^a   Poupon, Marie France ^a  

^a INSTITUT CURIE   (France)

Author keywords

Collective migration; Colonization; Cooperation; Metastasis; Microenvironment; Premetastatic niche

Indexed keywords

BETA1 INTEGRIN; CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD VESSEL; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER RESEARCH; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL SURVIVAL; COLORECTAL CANCER; EXTRACELLULAR MATRIX; EXTRAVASATION; HUMAN; METASTASIS; MICROENVIRONMENT; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR EMBOLISM; TUMOR LOCALIZATION;

ANIMALS; EXTRACELLULAR MATRIX; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 38549130224     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9103-x     Document Type: Review

References (60)

1. Bockhorn, M., Jain, R. K., & Munn, L. L. (2007). Active versus passive mechanisms in metastasis: Do cancer cells crawl into vessels, or are they pushed? Lancet Oncology, 8, 444-448.
2. Hoon, D. S., Kitago, M., Kim, J., Mori, T., Piris, A., Szyfelbein, K., et al. (2006). Molecular mechanisms of metastasis. Cancer and Metastasis Reviews, 25, 203-220.
3. Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563-572.
4. Steeg, P. S. (2006). Tumor metastasis: Mechanistic insights and clinical challenges. Nature Medicine, 12, 895-904.
5. Fidler, I. J. (2002). Critical determinants of metastasis. Seminars in Cancer Biology, 12, 89-96.
6. Fidler, I. J., & Kripke, M. L. (2003). Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nature Genetics, 34, 23.
7. Weiss, L. (2000). Metastasis of cancer: A conceptual history from antiquity to the 1990s. Cancer and Metastasis Reviews, 19, 193-383.
8. Kapoor, P., Saunders, M. M., Li, Z., Zhou, Z., Sheaffer, N., Kunze, E. L., et al. (2004). Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. International Journal of Cancer, 111, 693-697.
9. el-Sabban, M. E., & Pauli, B. U. (1994-1995). Adhesion-mediated gap junctional communication between lung-metastatic cancer cells and endothelium. Invasion Metastasis, 14, 164-176.
10. Opdenakker, G., & Van Damme, J. (2004). The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. International Journal of Developmental Biology, 48, 519-527.
11. Axelrod, R., Axelrod, D. E., & Pienta, K. J. (2006). Evolution of cooperation among tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 103, 13474-13479.
12. Glinsky, V. V. (2006). Intravascular cell-to-cell adhesive interactions and bone metastasis. Cancer and Metastasis Reviews, 25, 531-540.
13. Kerbel, R. S. (1994-1995). Impact of multicellular resistance on the survival of solid tumors, including micrometastases. Invasion Metastasis, 14, 50-60.
14. Nicolson, G. L. (1984). Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer and Metastasis Reviews, 3, 25-42.
15. Wittekind, C., & Neid, M. (2005). Cancer invasion and metastasis. Oncology, 69, 14-16.
16. Yamaguchi, H., Wyckoff, J., & Condeelis, J. (2005). Cell migration in tumors. Current Opinion in Cell Biology, 17, 559-564.
17. Thiery, J. P., & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews. Molecular Cell Biology, 7, 131-142.
18. Zaman, M. H., Trapani, L. M., Sieminski, A. L., Mackellar, D., Gong, H., Kamm, R. D., et al. (2006). Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proceedings of the National Academy of Sciences of the United States of America, 103, 10889-10894.
19. Jodele, S., Blavier, L., Yoon, J. M., & DeClerck, Y. A. (2006). Modifying the soil to affect the seed: Role of stromal-derived matrix metalloproteinases in cancer progression. Cancer and Metastasis Reviews, 25, 35-43.
20. Anderson, A. R., Weaver, A. M., Cummings, P. T., & Quaranta, V. (2006). Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell, 27, 905-915.
21. Palecek, S. P., Huttenlocher, A., Horwitz, A. F., & Lauffenburger, D. A. (1998). Physical and biochemical regulation of integrin release during rear detachment of migrating cells. Journal of Cell Science, 111, 929-940.
22. Kirfel, G., Rigort, A., Borm, B., & Herzog, V. (2004). Cell migration: mechanisms of rear detachment and the formation of migration tracks. European Journal of Cell Biology, 83, 717-724.
23. Friedl, P., Maaser, K., Klein, C. E., Niggemann, B., Krohne, G., & Zänker, K. S. (1997). Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Research, 57, 2061-2070.
24. Hegerfeldt, Y., Tusch, M., Bröcker, E. B., & Friedl, P. (2002). Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Research, 62, 2125-2130.
25. Brakebusch, C., & Fässler, R. (2005). Beta 1 integrin function in vivo: adhesion, migration and more. Cancer and Metastasis Reviews, 24, 403-411.
26. Christiansen, J. J., & Rajasekaran, A. K. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research, 66, 8319-8326.
27. Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997). General mechanisms of metastasis. Cancer, 80, 1529-1537.
28. Gupta, A., Deshpande, C. G., & Badve, S. (2003). Role of E-cadherins in development of lymphatic tumor emboli. Cancer, 97, 2341-2347.
29. Galaup, A., Cazes, A., Le Jan, S., Philippe, J., Connault, E., Le Coz, E., et al. (2006). Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proceedings of the National Academy of Sciences of the United States of America, 103, 18721-18726.
30. Siclari, V. A., Guise, T. A., & Chirgwin, J. M. (2006). Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer and Metastasis Reviews, 25, 621-633.
31. Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. New England Journal of Medicine, 351, 781-791.
32. Cristofanilli, M., Broglio, K. R., Guarneri, V., Jackson, S., Fritsche, H. A., Islam, R., et al. (2007). Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden. Clinical Breast Cancer, 7, 471-479.
33. Wiedswang, G., & Naume, B. (2007). Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer? Nature Clinical Practice. Oncology, 4, 154-155.
34. Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., et al. (1998). Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. American Journal of Pathology, 153, 865-873.
35. Cameron, M. D., Schmidt, E. E., Kerkvliet, N., Nadkarni, K. V., Morris, V. L., Groom, A. C., et al. (2000). Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Research, 60, 2541-2546.
36. Ito, S., Nakanishi, H., Ikehara, Y., Kato, T., Kasai, Y., Ito, K., et al. (2001). Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. International Journal of Cancer, 93, 212-217.
37. Weiss, L. (1996). Metastatic inefficiency: Intravascular and intraperitoneal implantation of cancer cells. Cancer Treatment and Research, 82, 1-11.
38. Khatib, A. M., Fallavollita, L., Wancewicz, E. V., Monia, B. P., & Brodt, P. (2002). Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Research, 62, 5393-5398.
39. Khatib, A. M., Kontogiannea, M., Fallavollita, L., Jamison, B., Meterissian, S., & Brodt, P. (1999). Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Research, 59, 1356-1361.
40. Khatib, A. M., Auguste, P., Fallavollita, L., Wang, N., Samani, A., Kontogiannea, M., et al. (2005). Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. American Journal of Pathology, 167, 749-759.
41. Auguste, P., Fallavollita, L., Wang, N., Burnier, J., Bikfalvi, A., & Brodt, P. (2007). The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. American Journal of Pathology, 170, 1781-1792.
42. Lafrenie, R., Shaughnessy, S. G., & Orr, F. W. (1992). Cancer cell interactions with injured or activated endothelium. Cancer and Metastasis Reviews, 11, 377-388.
43. Orr, F. W., Wang, H. H., Lafrenie, R. M., Scherbarth, S., & Nance, D. M. (2000). Interactions between cancer cells and the endothelium in metastasis. Journal of Pathology, 190, 310-329.
44. Ruiter, D. J., van Krieken, J. H., van Muijen, G. N., & de Waal, R. M. (2001). Tumour metastasis: Is tissue an issue? Lancet Oncology, 2, 109-112.
45. Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., et al. (2003). Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Research, 63, 3805-3811.
46. Hiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nature Cell Biology, 8, 1369-1375.
47. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438, 820-827.
48. Kaplan, R. N., Psaila, B., & Lyden, D. (2006). Bone marrow cells in the 'pre-metastatic niche': Within bone and beyond. Cancer and Metastasis Reviews, 25, 521-529.
49. Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., et al. (2005). A pooled analysis of bone marrow micrometastasis in breast cancer. New England Journal of Medicine, 353, 793-802.
50. Wiedswang, G., Borgen, E., Kåresen, R., Kvalheim, G., Nesland, J. M., Qvist, H., et al. (2003). Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. Journal of Clinical Oncology, 21, 3469-3478.
51. Bidard, F. C., Vincent-Salomon, A., Gomme, S., Thiery, J. P., Sigal-Zafrani, B., De Rycke, Y., et al. (2007). Bone marrow micrometastasis are a powerful prognostic factor in women with stage I to III breast cancer. (Abstract). AACR annual meeting.
52. Wiedswang, G., Borgen, E., Karesen, R., Qvist, H., Janbu, J., Kvalheim, G., et al. (2004). Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clinical Cancer Research, 10, 5342-5348.
53. Gangnus, R., Langer, S., Breit, E., Pantel, K., & Speicher, M. R. (2004). Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients. Clinical Cancer Research, 10, 3457-3464.
54. Braun, S., Hepp, F., Sommer, H. L., & Pantel, K. (1999). Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease. International Journal of Cancer, 84, 1-5.
55. Schmidt-Kittler, O., Ragg, T., Daskalakis, A., Granzow, M., Ahr, A., Blankenstein, T. J., et al. (2003). From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America, 100, 7737-7742.
56. Wiedswang, G., Borgen, E., Schirmer, C., Kåresen, R., Kvalheim, G., Nesland, J. M., et al. (2006). Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. International Journal of Cancer, 118, 2013-1019.
57. Bidard, F. C., Auger, N., Rosty, C., Assayag, F., Di Santo, J. P., & Poupon, M. F. (2007). Specific colonization of metastases by non metastasizing circulating tumor cells. (Abstract). AACR annual meeting.
58. Miller, F. R. (1983). Tumor subpopulation interactions in metastasis. Invasion Metastasis, 3, 234-242.
59. Bernards, R., & Weinberg, R. A. (2002). A progression puzzle. Nature, 418, 823.
60. Inamura, K., Shimoji, T., Ninomiya, H., Hiramatsu, M., Okui, M., Satoh, Y., et al. (2007). A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity. Human Pathology, 38, 702-709.